Atlantic Health Reduces Colonoscopy Screening Gaps Using Artera's AI Agents
Pioneering Use of AI-Driven Outreach Helps Improve Screening for Colorectal Cancer, the Leading Cause of Death for Adults Under 50 1
To help guide patients through the colonoscopy journey and close the screening gap, Atlantic Health, a leading not-for-profit health care system caring for patients throughout
The deployment of Artera's AI Agents has yielded immediate, measurable improvements. Within the first 30 days after launch:
- 43% of patients contacted by AI Agent successfully answered the phone calls and confirmed their identities
- 39% of patients confirmed that they will attend their upcoming colonoscopy appointments
- 7% of patients asked the AI Agent questions about the procedure
"We have, within our power, the ability to protect many patients from colorectal cancer, but that starts with screenings, specifically with a colonoscopy," said Ravish Parekh, MD, gastroenterologist with Atlantic Health. "By delivering personalized, easy-to-understand guidance, we hope to see better patient adherence and more effective exams. This initiative highlights Atlantic Health's dedication to patient-centered care through innovation."
Preparing for a colonoscopy involves complex, multi-day steps that can confuse patients, often leading to high cancellation and no-show rates. Atlantic Health recognized the necessity to simplify this process, aiming to ensure higher procedure completion percentages and better overall health outcomes, in addition to consistent, standardized GI outreach, communication and pre-appointment instructions across the entire organization.
By utilizing Artera's AI Agents, the health system was able to move beyond manual, inconsistent reminders and instructions to a standardized, AI-driven, digital-first experience.
"Colonoscopy prep is uniquely complex - every patient's journey is different, and there are so many steps to complete before the procedure. After reviewing our internal processes and patient feedback, it was clear there was a real opportunity to improve the experience," said
Transforming the Consumer Journey with AI Agents
Using Artera's AI Agents, Atlantic Health places automated calls to patients one week before their scheduled procedure to confirm the appointment, encourage the review of preparation materials, and answer patient inquiries.
The Agent is rigorously trained using a proprietary Atlantic Health knowledge base, allowing it to answer more than 80 Atlantic Health-approved clinical and operational frequently asked questions - without relying on external internet data sources. Furthermore, it honors individual patient preferences by speaking in multiple languages, including Spanish, and intelligently adjusts its conversational tone within clinical-guardrails to deliver a highly personalized experience.
This automated efficiency has drastically reduced the manual call volume for gastrointestinal procedure schedulers. By independently managing these critical touchpoints, the AI Agent has reduced the amount of time spent on these calls by 38 percent and empowered clinical and operational teams to refocus their efforts on high-level patient care while maximizing schedule utilization and driving higher completion rates for essential cancer screenings.
"As a pioneer adopter of agentic AI in healthcare and an Artera partner for more than six years, Atlantic Health recognizes that a modern patient journey requires modern, AI-driven solutions to solve decades-old challenges," said
About Atlantic Health
Atlantic Health is at the forefront of medicine, setting standards for quality health care in
The not-for-profit system offers more than 550 sites of care, including its eight hospitals: Atlantic Health Morristown Medical Center in
About Artera
Artera is the proven agentic healthcare company, leveraging a decade of deep expertise to support 2 billion patient communications annually. Our solutions empower humans and AI Agents to work together to fix patient communications across text, phone, and web, unifying the entire patient journey - from scheduling and intake to billing and more. Trusted by over 1,000 healthcare organizations (including specialty groups, FQHCs, large IDNs, and federal agencies), Artera directly increases staff efficiency, boosts patient engagement, and improves the provider bottom line, helping patients get the care they need with simplicity and speed.
2B+ Annual Comms. | 200M+ Patients | 10yrs Experience | FedRAMP High in Process | www.artera.io
Note on AI Implementation: Artera's AI Agents are designed to supplement, not replace, the professional medical judgment of healthcare providers. All clinical content and preparation instructions delivered via the AI Agent are provided and approved exclusively by Atlantic Health. Patients are encouraged to contact their clinical team directly for medical emergencies or specific health concerns.
Forward-Looking Statements: This press release contains forward-looking statements. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially.
1 JAMA / ACS, "Mortality Under 50 Declines for 4 of 5 Leading Cancers in
2 American Cancer Society, "Colorectal Cancer Statistics, 2026"
3 Colorectal Cancer Alliance, "Preventing, detecting and treating colorectal cancer" (March 2026).
4 ACS National Colorectal Cancer Roundtable (NCCRT), 2026 Data and Progress Report.
View original content to download multimedia:https://www.prnewswire.com/news-releases/atlantic-health-reduces-colonoscopy-screening-gaps-using-arteras-ai-agents-302727557.html
SOURCE Artera
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kreyco Calls for Independent Investigation into NYC Department of Education Contracting, Oversight, Student Protection, and Accountability Practices
- Innovent's Partner Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of IBI324 (OLN324) in DME and Wet AMD; Studies Commencing in Second
- Legacy Receives New York State CLEP Approval for Two Laboratory-Developed Tests: Semen Analysis and DNA Fragmentation
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share